Loading...
Docoh

Applied Genetic Technologies (AGTC)

News

From Benzinga Pro
Chardan Capital Maintains Buy on Applied Genetic, Lowers Price Target to $5
18 May 22
News, Price Target, Analyst Ratings
Chardan Capital analyst Daniil Gataulin maintains Applied Genetic (NASDAQ:AGTC) with a Buy and lowers the price target from $8 to $5.
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
17 May 22
Biotech, Earnings, Large Cap, News, Penny Stocks, Health Care, Small Cap, FDA, Legal, Management, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
17 May 22
Biotech, News, Penny Stocks, Health Care, General
AGTC Announces Three-Month Interim Results From Skyline Trial Of AGTC-501 For The Treatment Of X-Linked Retinitis Pigmentosa
16 May 22
Biotech, News, FDA, General
– 62.5% of Patients in Dose Group B Were Responders for Improvements in Visual Sensitivity, the Study’s Primary Efficacy Endpoint – – Continued Strong Safety Data – – Robust Safety
Stocks That Hit 52-Week Lows On Wednesday
11 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 807 companies reached new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
6 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
4 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Wednesday's trading, 435 companies set new 52-week lows.
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
4 May 22
Biotech, Earnings, Large Cap, News, Penny Stocks, Health Care, Financing, Offerings, Small Cap, FDA, Movers, Trading Ideas, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Applied Genetic Technologies Announces 18-Month Data From Ongoing Phase 1/2 Clinical Study Of AGTC-501 Presented At The Association For Research In Vision And Ophthalmology 2022 Annual Meeting
4 May 22
Biotech, News, Events, General
Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
2 May 22
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, IPOs
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks during the week.
Stocks That Hit 52-Week Lows On Wednesday
27 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
30 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 29 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
29 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Tuesday, 81 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
25 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 166 companies set new 52-week lows.
66 Biggest Movers From Yesterday
23 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement.
Mid-Afternoon Market Update: HireRight Rises Following Q4 Results; Applied Genetic Technologies Shares Fall
22 Mar 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 200 points on Tuesday.
12 Health Care Stocks Moving In Tuesday's Intraday Session
22 Mar 22
Intraday Update, Markets, Movers
Stocks That Hit 52-Week Lows On Tuesday
22 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Tuesday's session saw 52 companies set new 52-week lows.
Mid-Day Market Update: Dow Jumps Over 200 Points; ORIC Pharmaceuticals Shares Slide
22 Mar 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.
42 Stocks Moving In Tuesday's Mid-Day Session
22 Mar 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business combination with Motive Capital Corp on the 22nd of March, 2022.

Press releases

From Benzinga Pro
AGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa
16 May 22
Press Releases, General
– 62.5% of Patients in Dose Group B Were Responders for Improvements in Visual Sensitivity, the Study's Primary Efficacy Endpoint – – Continued Strong Safety Data – – Robust Safety and Efficacy Data Consistent with
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
4 May 22
Press Releases
– Data reconfirm previously highlighted safety and efficacy potential of AGTC-501 as a treatment for X-linked retinitis pigmentosa (XLRP) – GAINESVILLE, Fla., and CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE)
AGTC to Present Preclinical Research Supporting Gene Therapy Platform in Frontotemporal Dementia at the 25th Annual Meeting of the American Society of Gene & Cell Therapy
2 May 22
News, Press Releases
GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical stage biotechnology company focused on the development of adeno-associated
AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
4 Apr 22
News, Press Releases
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical stage biotechnology company focused on the development of adeno-associated
AGTC Announces Pricing of Public Offering of Common Stock
22 Mar 22
News, Financing, Press Releases
GAINESVILLE, Fla., and CAMBRIDGE, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical-stage biotechnology company focused on the development and
AGTC Announces Proposed Public Offering of Common Stock
21 Mar 22
Press Releases
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical-stage biotechnology company focused on the development and commercialization
AGTC to Participate in Upcoming Investor Conferences
8 Mar 22
News, Health Care, Press Releases
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical stage biotechnology company focused on the development and commercialization